News

“These results represent a significant milestone for PALI-2108,” said JD Finley, Chief Executive Officer of Palisade Bio. “The early clinical activity, targeted delivery, dose flexibility, the ...
Microbiotica has completed patient recruitment for its phase 1b trial, COMPOSER-1, evaluating MB310 in adults with ulcerative ...
Patients with inflammatory bowel disease (IBD) have a 48% greater relative risk of developing interstitial lung disease (ILD) ...
NDA for icotrokinra for the treatment of adults and adolescents 12 years of age and older with moderate to severe plaque ...
Palisade Bio, Inc. (($PALI)) announced an update on their ongoing clinical study. Study Overview: Palisade Bio, Inc. has completed a Phase 1 ...
Devonian Health Group Inc. ("Devonian" or the "Corporation") (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused ...
More than half of adults with inflammatory bowel disease have at least one psychiatric comorbidity, according to research ...
Burnout is among the reasons girls are dropping out of sports at two times the rate of boys. Gotham FC has been working to keep players in the game.
In the assessment of 12-month price targets, analysts unveil insights for AnaptysBio, presenting an average target of $63.25, ...
Manufacturers of PFAS-containing products, Chemours, DuPont, and Corteva agreed to pay $875 million over the next 25 years to ...
SAN DIEGO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today reported financial ...
Probiotics can help the body get more out of the protein that is consumed either by producing enzymes that directly break ...